RISK FACTORS AND PREDICTORS OF SEVERE ADVERSE DRUG REACTIONS IN CLINICAL PRACTICE

Authors

  • Narayana Swamy Palyam Department of Pharmacy Practice, Jagan’s institute of pharmaceutical science, spsp Nellore, Andhra Pradesh, India.

Keywords:

Severe adverse drug reactions, Risk factors, Predictors, Clinical practice, Pharmacovigilance, Polypharmacy, Genetic predisposition

Abstract

Severe adverse drug reactions (ADRs) are a significant cause of morbidity, mortality, and healthcare resource utilization in clinical practice. Identifying risk factors and predictors is essential for early detection, prevention, and management. Risk factors are multifactorial, encompassing patient-related variables (age, sex, comorbidities, genetic predisposition), drug-related factors (polypharmacy, narrow therapeutic index, drug interactions), and system-related determinants (medication errors, lack of monitoring). Predictors of severe ADRs include previous drug hypersensitivity, renal or hepatic impairment, concomitant high-risk medications, and pharmacogenetic markers. This review provides an in-depth discussion on epidemiology, mechanisms, clinical predictors, risk stratification tools, and strategies to mitigate severe ADRs in clinical settings. Integration of pharmacovigilance, electronic monitoring systems, and personalized medicine is highlighted as a key approach for optimizing patient safety.

Downloads

Download data is not yet available.

Author Biography

Narayana Swamy Palyam, Department of Pharmacy Practice, Jagan’s institute of pharmaceutical science, spsp Nellore, Andhra Pradesh, India.

Department of Pharmacy Practice, Jagan’s institute of pharmaceutical science, spsp Nellore, Andhra Pradesh, India.

References

1. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ. 2004;329(7456):15–19.

2. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis. JAMA. 1998;279(15):1200–1205.

3. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255–1259.

4. Lindquist M. VigiBase, the WHO Global ICSR database system: basic facts. Drug Inf J. 2008;42(5):409–419.

5. World Health Organization. Safety of medicines: a guide to detecting and reporting adverse drug reactions. WHO; 2002.

6. Pirmohamed M. Predicting adverse drug reactions in hospitalized patients. Br J Clin Pharmacol. 2010;70(5):701–703.

7. Roughead EE, Semple SJ. Adverse drug reactions and hospital admissions in the elderly. Drug Saf. 2009;32(5):427–434.

8. Chung WH, Hung SI, Hong HS, et al. Medical genetics: a marker for Stevens–Johnson syndrome. Nature. 2004;428(6982):486.

9. Trubiano JA, Phillips EJ. Pharmacogenetics: predicting drug hypersensitivity reactions. Clin Pharmacol Ther. 2013;93(1):13–15.

Downloads

Published

2025-12-24

How to Cite

[1]
Palyam, N.S. 2025. RISK FACTORS AND PREDICTORS OF SEVERE ADVERSE DRUG REACTIONS IN CLINICAL PRACTICE. Journal of Drug Reactions. 1, 1 (Dec. 2025), 10–13.

Issue

Section

Articles